title: [Outcomes of treatment of chemotherapy drugs different manufacturers tuberculosis patients with multiple drug resistance].
abstract: The article is devoted to studying the effectiveness of treatment of tuberculosis (TB) patients with multidrug-resistant TB drugs 2 number of different manufacturers. To assess the effectiveness of treatment of second-line drugs were taken to study two groups of patients: Group 1 - 164 patients who received anti-TB drugs from the Global Fund and Group 2 174 patients who received anti-TB drugs for the national program. Comparative evaluation showed high efficiency second-line drugs from the Global Fund, as evidenced by the high level of 95,8 % abacillation in a short time in this patient group.
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018432:Drug Resistance, Multiple / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012922:Social Change; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000145:classification / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000995:Antitubercular Agents